Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway

Nonalcoholic fatty liver disease (NAFLD) represents one of the most common chronic liver diseases in the world. It has been reported that epigallocatechin-3-gallate (EGCG) plays important biological and pharmacological roles in mammalian cells. Nevertheless, the mechanism underlying the beneficial e...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oxid Med Cell Longev
Auteurs principaux: Wu, Dongdong, Liu, Zhengguo, Wang, Yizhen, Zhang, Qianqian, Li, Jianmei, Zhong, Peiyu, Xie, Zhongwen, Ji, Ailing, Li, Yanzhang
Format: Artigo
Langue:Inglês
Publié: Hindawi 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8068552/
https://ncbi.nlm.nih.gov/pubmed/33953830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5599997
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires